AI Infrastructure
Semiconductors and power equipment that benefit as AI capex flows from chips to grids.
Start Here
Follow Korea Stocks Through Business Quality, Not Headlines
MoatAlpha focuses on undercovered Korean companies with durable advantages, real operating leverage, and long-term rerating potential.
Industrial & Energy
Shipbuilding and hard-asset businesses exposed to LNG, global logistics, and capital cycles.
Biotech Platforms
Korean healthcare companies with platform economics, licensing leverage, and asymmetric upside.
KEPCO KPS Analysis: Nuclear Maintenance Monopoly
KEPCO KPS analysis: Korea’s nuclear maintenance monopoly posted record $152M operating profit. Czech exports, Romania contract, and 4% dividend yield.
Samsung Biologics Analysis: Record Profit, 45% Margins
Samsung Biologics analysis: record $3.1B revenue, 45% operating margin, and 845,000L capacity make this the dominant CDMO play for global biopharma investors.
Hyundai Rotem Analysis: Record Profit, $10B Backlog
Hyundai Rotem Just Crossed $690 Million in Operating Profit — For the First Time Ever Hyundai Rotem was once the “ugly duckling” of the Hyundai Motor Group. For years, it posted losses and was considered a drag on the conglomerate. … Read more
HD Korea Shipbuilding: $20B Revenue, 172% Profit Surge
HD Korea Shipbuilding Just Hit $2.7 Billion in Operating Profit — Here’s the Full Picture In 2022, HD Korea Shipbuilding & Offshore Engineering (HD KSOE) posted an operating loss. In 2025, it posted ₩3.9 trillion ($2.67 billion) in operating profit … Read more
HD Hyundai Electric: 27.6% Margin, $6.7B Backlog
HD Hyundai Electric Just Hit a 27.6% Operating Margin — Here’s Why That’s Extraordinary HD Hyundai Electric logo · Source: HD현대일렉트릭 In 2021, HD Hyundai Electric’s operating profit was ₩9.7 billion ($6.6 million). In 2025, it was ₩995.3 billion ($682 … Read more
SK Hynix Analysis: The AI Memory Monopoly at $13B Profit
$33 Billion in Operating Profit, 49% Margins — What Is Happening at SK Hynix? Revenue of $67.2 billion (KRW 97.1 trillion). Operating profit of $32.7 billion (KRW 47.2 trillion). Operating margin of 49%. These are the full-year 2025 numbers for … Read more
Alteogen Analysis: 275% Profit Surge, Hidden Biotech Gem
Biotech researcher reviewing clinical trial data · Photo: National Cancer Institute / Unsplash Alteogen Just Posted Record Numbers — Here’s Why It Matters Revenue of ₩202.1 billion ($145M). Operating income of ₩114.8 billion ($82M). An operating margin of 57%. Three … Read more